Biomarkers in lung cancer screening: achievements, promises and challenges.
Seijo LM, Peled N, Ajona D,
Boeri M, Field JK, Sozzi G, Pio R, Zulueta JJ, Spira A, Massion PP, Mazzone PJ, Montuenga LM.
J Thorac Oncol. 2018 Dec 4. pii: S1556-0864(18)33501-9. doi: 10.1016/j.jtho.2018.11.023. Review.

2018

Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk.
Fortunato O, Borzi C, Milione M, Centonze G, Conte D, Boeri M, Verri C, Moro M, Facchinetti F, Andriani F, Roz L, Caleca L, Huber V, Cova A, Camisaschi C, Castelli C, Cancila V, Tripodo C, Pastorino U, Sozzi G.
Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31988

2018

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.
Tuccitto A, Shahaj E, Vergani E, Ferro S, Huber V, Rodolfo M, Castelli C, Rivoltini L, Vallacchi V.
Virchows Arch. 2018 Oct 29. doi: 10.1007/s00428-018-2477-z

2018

A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemically labeled tissue sections
Casiraghi E, Huber V, Frasca M, Cossa M, Tozzi M, Rivoltini L, Leone BE, Villa A and Vergani B.
BMC Bioinformatics 2018 Oct 15;19(Suppl 10):357. doi: 10.1186/s12859-018-2302-3.

2018

p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression.
Amelio I, Mancini M, Petrova V, Cairns RA, Vikhreva P, Nicolai S, Marini A, Antonov AA, Le Quesne J, Baena Acevedo JD, Dudek K, Sozzi G, Pastorino U, Knight RA, Mak TW, Melino G.
Proc Natl Acad Sci U S A.
2018 Oct 31. pii: 201808314.
doi: 10.1073/pnas.1808314115

2018

Effect of Tobacco Smoking Cessation on C-Reactive Protein Levels in A Cohort of Low-Dose Computed Tomography Screening Participants.
Gallus S, Lugo A, Suatoni P, Taverna F, Bertocchi E, Boffi R, Marchiano A, Morelli D,
Pastorino U.
Sci Rep. 2018 Aug 27;
8(1):12908. doi: 10.1038/s41598-018-29867-9.

2018

ECM Remodelling in Breast Cancer with Different Grade: Contribution of 2D-DIGE Proteomics.
Moriggi M, Giussani M, Torretta E, Capitanio D, Sandri M, Leone R, De Palma S, Vasso M, Vozzi G, Tagliabue E, Gelfi C.
Proteomics. 2018 Oct 24:e1800278. doi: 10.1002/pmic.201800278.

2018

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.
Huber V, Vallacchi V, Fleming V, Hu X, Cova A, Dugo M, Shahaj E, Sulsenti R, Vergani E, Filipazzi P, De Laurentiis A, Lalli L, Di Guardo L, Patuzzo R, Vergani B, Casiraghi E, Cossa M, Gualeni A, Bollati V, Arienti F, De Braud F, Mariani L, Villa A, Altevogt P, Umansky V, Rodolfo M, Rivoltini L.
J Clin Invest. 2018 Sep 27. pii: 98060. doi: 10.1172/JCI98060.

2018

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer
Andriani F, Landoni E, Mensah M, Facchinetti F, Miceli R, Tagliabue E, Giussani M, Callari M, De Cecco L, Colombo MP, Roz L, Pastorino U, Sozzi G
BMC Cancer. 2018
Sep 18;18(1):899.
doi: 10.1186/s12885-018-4772-0.

2018

Mechanisms of tumor immunotherapy, with a focus on thoracic cancers
Ferro S, Huber V, Rivoltini L
J Thorac Dis. 2018
Jul;10(7):4619-4631.
doi: 10.21037/jtd.2018.07.30.

2018

MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1 and MEK1-dependent manner
Andriani F, Majorini MT, Mano M, Landoni E, Miceli R, Facchinetti F, Mensah M, Fontanella E, Dugo M, Giacca M, Pastorino U, Sozzi G, Delia D, Roz L, Lecis D
Journal of Hematology &
Oncology (2018) 11:45

2018

Extracellular matrix proteins as diagnostic markers of breast carcinoma.
Giussani M, Landoni E, Merlino G, Turdo F, Veneroni S, Paolini B, Cappelletti V, Miceli R, Orlandi R, Triulzi T, Tagliabue E.
J Cell Physiol. 2018 Mar 9.
doi: 10.1002/jcp.26513.

2018

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Progetto finanziato con

il contributo Airc 5x1000

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié